Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Research Articles

Original Research
The Impact of the COVID-19 Pandemic on the Treatment of Myocardial Infarction: A Single Center Experience
12/16/2021
Evaluation of the impact of the COVID-19 pandemic on MI treatment and outcomes.
Evaluation of the impact of the COVID-19 pandemic on MI treatment and outcomes.
Evaluation of the impact of the...
12/16/2021
Vascular Disease Management
Original Research
Common Femoral Artery Anatomy and Relations to Bony Landmarks: A Computed Tomography Angiogram Study
11/18/2021
This study aimed to provide a descriptive anatomy of the CFA .
This study aimed to provide a descriptive anatomy of the CFA .
This study aimed to provide a...
11/18/2021
Vascular Disease Management
Original Research
Use of a Novel, Intermittent Pneumatic Compression Device to Promote Perforator Vein Dilation in Patients with Chronic Renal Failure: The pFACT Trial
10/20/2021
The Fist Assist Model FA-1
The Fist Assist Model FA-1
The Fist Assist Model FA-1
10/20/2021
Vascular Disease Management
Original Research
Safety, Efficacy, and Comfort of the Transradial Approach Using the Radial to Peripheral Destination Slender Guiding Sheath
09/16/2021
In this descriptive study, the authors sought to determine the feasibility of the transradial approach for peripheral intervention using the R2P Destination Slender Guiding Sheath.
In this descriptive study, the authors sought to determine the feasibility of the transradial approach for peripheral intervention using the R2P Destination Slender Guiding Sheath.
In this descriptive study, the...
09/16/2021
Vascular Disease Management
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
Original Research
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
08/01/2021
The purpose of this study is to determine the prevalence of unsuspected hemodynamically significant coronary stenosis in CLI patients and to assess the potential benefit of FFRct analysis in patient management.
The purpose of this study is to determine the prevalence of unsuspected hemodynamically significant coronary stenosis in CLI patients and to assess the potential benefit of FFRct analysis in patient management.
The purpose of this study is to...
08/01/2021
Vascular Disease Management
Original Research
Descriptive Study of Ulcers Treated in a Diabetic Foot Unit
05/03/2021
This is a descriptive study of a cohort of patients treated at the DFU of the Vascular Department of the Hospital Universitario Fundación Alcorcón between November 2009 and September 2012.
This is a descriptive study of a cohort of patients treated at the DFU of the Vascular Department of the Hospital Universitario Fundación Alcorcón between November 2009 and September 2012.
This is a descriptive study of a...
05/03/2021
Vascular Disease Management
Original Research
Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound
03/04/2021
More than 80 million Americans suffer from chronic venous disease, which often is visually recognized as varicose veins. If left untreated, these abnormal leg veins can progressively worsen and cause other complications.
More than 80 million Americans suffer from chronic venous disease, which often is visually recognized as varicose veins. If left untreated, these abnormal leg veins can progressively worsen and cause other complications.
More than 80 million Americans...
03/04/2021
Vascular Disease Management
Original Research
Correlation Between Ankle Brachial Index and SYNTAX Score to Predict Severity of Coronary Artery Disease
02/26/2021
Atherosclerosis is a disease of the large and medium-sized arteries resulting in luminal stenosis, resulting from accumulation of lipids and fibrosis between the arterial intima and its media.
Atherosclerosis is a disease of the large and medium-sized arteries resulting in luminal stenosis, resulting from accumulation of lipids and fibrosis between the arterial intima and its media.
Atherosclerosis is a disease of...
02/26/2021
Vascular Disease Management
Original Research
The Vascade Vascular Closure System Performance Guarantee Risk-Sharing Agreement: Low Prevalence of Closure-Related Complications
12/17/2020
Although the prevalence of radial catheterization is increasing, many cardiac procedures and most peripheral angiography and interventional procedures are performed via femoral vascular access.
Although the prevalence of radial catheterization is increasing, many cardiac procedures and most peripheral angiography and interventional procedures are performed via femoral vascular access.
Although the prevalence of...
12/17/2020
Vascular Disease Management
Original Research
Effect of Nitrate Administration on Peak Systolic Velocity in Peripheral Arterial Disease Patients at Sardjito General Hospital in Yogyakarta
11/18/2020
Little is known about the role of nitrate or nitric oxide administration to improve symptomatic PAD patients. The purpose of this study is to observe the effect of nitrate administration on peak systolic velocity ratios in PAD patients.
Little is known about the role of nitrate or nitric oxide administration to improve symptomatic PAD patients. The purpose of this study is to observe the effect of nitrate administration on peak systolic velocity ratios in PAD patients.
Little is known about the role...
11/18/2020
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement